
CHAMPIONX CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Reminds ChampionX Corporation Investors to Contact the Firm Regarding Lead Plaintiff Role Before July 14th
GlobeNewsWire
Published: Jul 07, 2026, 03:50 AM GMT+9
Sentiment Analysis
If you sold common stock of ChampionX between February 29, 2024 and April 1, 2024 and would like to discuss your legal rights, contact Bragar Eagel & Squire partners Brandon Walker or Melissa Fortunato by email at [email protected] or by telephone at (212) 355-4648. Click here to participate in the action. NEW YORK, July 06, 2026 (GLOBE NEWSWIRE) -- What’s Happening? Bragar Eagel & Squire, P.C ., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against ChampionX Corporation (“ChampionX” or the “Company”) (NASDAQ:CHX) in the United States District Court for the Southern District of New York on behalf of all persons and entities who sold common stock of ChampionX between February 29, 2024 and April 1, 2024, both dates inclusive (the “Class Period”). Investors have until July 14, 2026 to apply to the Court to be appointed as lead plaintiff in the lawsuit. What are the Allegation Details? According to the lawsuit, defendants throughout the Class Period failed to disclose material information, which artificially deflated the price of ChampionX common stock. On February 29, 2024, ChampionX received an unsolicited non-public offer from Schlumberger Limited to purchase all the outstanding shares of ChampionX for $36.70 per share. On March 7, 2024, Schlumberger raised its offer to $37.80 per share. The lawsuit alleges that while these offers were on the table and unknown to the investing public, ChampionX was repurchasing its common stock at market prices significantly below the prices offered by Schlumberger. ChampionX had an obligation to disclose that it had received a formal acquisit...
Source: GlobeNewsWire
This content is not intended as investment advice or a recommendation. Any opinions expressed are solely the personal views of each article.